UROV - ウロバント・サイエンシズ （Urovant Sciences Ltd.）

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 62.9% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%. Trading Activity Trading volume this week was 4.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.5% The company's stock price performance over the past 12 months lags the peer average by -42.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 60.0% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%. Trading Activity Trading volume this week was 4.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 0.0% higher than its 5-day moving average, 0.2% higher than its 20-day moving average, and 0.6% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.5% The company's stock price performance over the past 12 months lags the peer average by -45.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 108.7% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.8%. Trading Activity Trading volume this week was 25.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.7% The company's stock price performance over the past 12 months lags the peer average by -30.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.3% below its 52 week high of $16.25, giving the company a market cap of $530M. The stock is currently up 0.4% year-to-date, up 25.9% over the past 12 months, and up 39.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 15.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.6% The company's stock price performance over the past 12 months lags the peer average by -59.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.3% below its 52 week high of $16.25, giving the company a market cap of $530M. The stock is currently up 0.4% year-to-date, up 26.3% over the past 12 months, and up 39.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 77.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -99.6% The company's stock price performance over the past 12 months lags the peer average by -77.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 62.9% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%. Trading Activity Trading volume this week was 4.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.5% The company's stock price performance over the past 12 months lags the peer average by -42.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 60.0% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%. Trading Activity Trading volume this week was 4.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 0.0% higher than its 5-day moving average, 0.2% higher than its 20-day moving average, and 0.6% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.5% The company's stock price performance over the past 12 months lags the peer average by -45.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 108.7% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.8%. Trading Activity Trading volume this week was 25.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.7% The company's stock price performance over the past 12 months lags the peer average by -30.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.3% below its 52 week high of $16.25, giving the company a market cap of $530M. The stock is currently up 0.4% year-to-date, up 25.9% over the past 12 months, and up 39.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 15.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.6% The company's stock price performance over the past 12 months lags the peer average by -59.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.3% below its 52 week high of $16.25, giving the company a market cap of $530M. The stock is currently up 0.4% year-to-date, up 26.3% over the past 12 months, and up 39.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 77.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -99.6% The company's stock price performance over the past 12 months lags the peer average by -77.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 62.9% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%. Trading Activity Trading volume this week was 4.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.5% The company's stock price performance over the past 12 months lags the peer average by -42.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 60.0% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%. Trading Activity Trading volume this week was 4.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 0.0% higher than its 5-day moving average, 0.2% higher than its 20-day moving average, and 0.6% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.5% The company's stock price performance over the past 12 months lags the peer average by -45.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.1% below its 52 week high of $16.26, giving the company a market cap of $531M. The stock is currently up 0.7% year-to-date, up 108.7% over the past 12 months, and up 39.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 0.8%. Trading Activity Trading volume this week was 25.5% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.7% The company's stock price performance over the past 12 months lags the peer average by -30.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.3% below its 52 week high of $16.25, giving the company a market cap of $530M. The stock is currently up 0.4% year-to-date, up 25.9% over the past 12 months, and up 39.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.9%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 15.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -98.6% The company's stock price performance over the past 12 months lags the peer average by -59.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Urovant Sciences Ltd. shares closed today at 0.3% below its 52 week high of $16.25, giving the company a market cap of $530M. The stock is currently up 0.4% year-to-date, up 26.3% over the past 12 months, and up 39.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 77.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -99.6% The company's stock price performance over the past 12 months lags the peer average by -77.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.